PETMED EXPRESS INC
No enriched coverage for $PETS in the last 7 days.
No SEC Form 4 filings for $PETS in the last 30 days.
PETMED EXPRESS INC (PETS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. pets-20260723 0001040130 FALSE 0001040130 2026-07-23 2026-07-23 0001040130 us-gaap:CommonStockMember 2026-07-23 2026-07-23 0001040130 us-gaap:PreferredStockMember 2026-07-23 2026-07-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT
PetMeds (PetMed Express, Inc., parent of PetCareRx, Nasdaq: PETS) said its new co-branded online pet pharmacy with Rural King is live via RuralKing.com and RuralKing.PetMeds.com. The platform offers pet medications, prescription food, preventatives and AutoShip for recurring needs. Intro offers include 25% off sitewide (RKPAW25) and 50% off first AutoShip (RKKING50).
PETMED EXPRESS INC (PETS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. pets-20260623 0001040130 FALSE 0001040130 2026-06-23 2026-06-23 0001040130 us-gaap:CommonStockMember 2026-06-23 2026-06-23 0001040130 us-gaap:PreferredStockMember 2026-06-23 2026-06-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT
Recent PETS coverage spans financial news, corporate actions and insider activity.
The filing discloses a new real-estate monetization and leaseback structure that can affect near-term liquidity and future rent expense.
The Rural King white-label launch expands PetMeds distribution and could support incremental revenue, but the article provides no financial targets or scale metrics.
Board composition change risk; may affect governance/committee continuity but no operational or financial guidance changes were disclosed.
The filing signals continued insider/institutional accumulation, but the disclosed dollar amount is small versus typical PETS liquidity/market cap, limiting near-term price impact.
Earnings call highlights a deteriorating top line and large loss, partially offset by compliance recovery, cost cuts, and tech initiatives.
alphai scores every news story that mentions PETS with an AI model for sentiment and relevance, and aggregates insider trades from PETMED EXPRESS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
PETMED EXPRESS INC (PETS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. pets-20260723 0001040130 FALSE 0001040130 2026-07-23 2026-07-23 0001040130 us-gaap:CommonStockMember 2026-07-23 2026-07-23 0001040130 us-gaap:PreferredStockMember 2026-07-23 2026-07-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT
5 min readPetMeds (PetMed Express, Inc., parent of PetCareRx, Nasdaq: PETS) said its new co-branded online pet pharmacy with Rural King is live via RuralKing.com and RuralKing.PetMeds.com. The platform offers pet medications, prescription food, preventatives and AutoShip for recurring needs. Intro offers include 25% off sitewide (RKPAW25) and 50% off first AutoShip (RKKING50).
4 min readPETMED EXPRESS INC (PETS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. pets-20260623 0001040130 FALSE 0001040130 2026-06-23 2026-06-23 0001040130 us-gaap:CommonStockMember 2026-06-23 2026-06-23 0001040130 us-gaap:PreferredStockMember 2026-06-23 2026-06-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT
2 min readNINA CAPITAL HOLDINGS INC. purchased 25,000 shares of PETMED EXPRESS INC (PETS) at $1.75 on 2026-06-08.
1 min readPetMed Express (PETS) reported fiscal 2026 net sales down 21.1% and a full-year net loss of $57.3 million, including $26.7 million goodwill impairment and $2.1 million inventory write-down, plus $4.5 million in non-recurring legal/severance costs tied to a whistleblower probe. The company said it regained regulatory compliance, fixed three material weaknesses, exited underperforming vendors for ~$6.1 million annualized savings, and saw its first Q4 sequential net sales increase since 2024.
4 min readPetMed Express Inc. (NASDAQ: PETS) stock has recently surged by 67.8%, driven by investor optimism and strategic moves, despite some financial setbacks. The company's introduction of a new Holiday Collection and the extension of its shareholder rights plan are seen as attempts to enhance value and protect against potential takeovers. While recent earnings showed a decrease in revenue and a detrimental profit margin, the steady gross margin and low valuation indicators suggest potential for a rebound.
4 min readDELRAY BEACH, Fla., Nov. 26, 2025 ( GLOBE NEWSWIRE ) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, ( Nasdaq: PETS ) ( the "Company" ) , today announced that its Board of Directors ( the "Board" ) has unanimously approved an amendment to the Company's existing ...
3 min readSeasoned corporate director brings extensive expertise in audit, accounting, and internal controls ...
2 min readBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed ( PETS ) To Contact Him Directly To Discuss Their Options
2 min readDELRAY BEACH, Fla., Oct. 14, 2025 ( GLOBE NEWSWIRE ) -- PetMed Express, Inc. ( the "Company" ) dba PetMeds and parent company of PetCareRx ( NASDAQ: PETS ) today filed with the Securities and Exchange Commission ( SEC ) its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.
3 min read
